home · filing · 0000105770-21-000076
8-K/A filed August 24, 2021, 7:59 PM ET
ticker WST
CIK 0000105770
leadership
confidence high
sentiment neutral
materiality 0.35
West Pharma corrects prior 8-K: Molly Joseph was CEO of UnitedHealthcare Global, not UnitedHealthcare Group
WEST PHARMACEUTICAL SERVICES INC
Molly Joseph elected to Board on Aug 19, 2021; board size increased to 11.
Corrected title: former CEO of UnitedHealthcare Global and EVP of UnitedHealth Group.
Expected to serve on Finance and Innovation & Technology Committees.
Compensation: $90k annual retainer plus $190k RSU grant, prorated for service.
Joseph also serves on First Solar board and Santa Clara University trustees.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-08-19
Filed August 24, 2021, 7:59 PM ET
On August 19, 2021, the Company elected Molly Joseph to its Board as its newest member.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Molly Joseph was elected as Director at WEST PHARMACEUTICAL SERVICES INC.
Action elected
Role Director
Exact text from the filing
On August 19, 2021, the Company elected Molly Joseph to its Board as its newest member.
View on SEC.gov
Source: SEC EDGAR
accession 0000105770-21-000076
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.